Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo (original) (raw)

• Emanuel, B.S. et al. The 2p breakpoint of a 2;8 translocation in Burkitt lymphoma interrupts the V kappa locus. Proc. Natl. Acad. Sci. USA 81, 2444–2446 (1984).
  Article CAS Google Scholar
• Mushinski, J.F., Potter, M., Bauer, S.R. & Reddy, E.P. DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. Science 220, 795–798 (1983).
  Article CAS Google Scholar
• Vogelstein, B. & Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med. 10, 789–799 (2004).
  Article CAS Google Scholar
• Darnell, J.E., Jr. Transcription factors as targets for cancer therapy. Nat. Rev. Cancer 2, 740–749 (2002).
  Article CAS Google Scholar
• Wang, L.H., Yang, X.Y., Kirken, R.A., Resau, J.H. & Farrar, W.L. Targeted disruption of stat6 DNA binding activity by an oligonucleotide decoy blocks IL-4-driven T(H)2 cell response. Blood 95, 1249–1257 (2000).
  CAS PubMed Google Scholar
• Turkson, J. et al. Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity. Mol. Cancer Ther. 3, 261–269 (2004).
  CAS PubMed Google Scholar
• Jing, N. et al. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis. Cancer Res. 64, 6603–6609 (2004).
  Article CAS Google Scholar
• Mateo-Lozano, S. et al. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma. Clin. Cancer Res. 12, 6781–6790 (2006).
  Article CAS Google Scholar
• Sumida, T., Itahana, Y., Hamakawa, H. & Desprez, P.Y. Reduction of human metastatic breast cancer cell aggressiveness on introduction of either form a or B of the progesterone receptor and then treatment with progestins. Cancer Res. 64, 7886–7892 (2004).
  Article CAS Google Scholar
• Lee, K.T. et al. Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers. Br. J. Cancer 90, 1198–1203 (2004).
  Article CAS Google Scholar
• Vandeputte, D.A. et al. Expression and distribution of id helix-loop-helix proteins in human astrocytic tumors. Glia 38, 329–338 (2002).
  Article Google Scholar
• Minn, A.J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518–524 (2005).
  Article CAS Google Scholar
• Gupta, G.P. et al. ID genes mediate tumor re-initiation during breast cancer lung metastasis. Proc. Natl. Acad. Sci. USA (in the press).
• Lyden, D. et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670–677 (1999).
  Article CAS Google Scholar
• de Candia, P. et al. Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors. Proc. Natl. Acad. Sci. USA 100, 12337–12342 (2003).
  Article CAS Google Scholar
• Ruzinova, M.B. et al. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4, 277–289 (2003).
  Article CAS Google Scholar
• Li, H., Gerald, W.L. & Benezra, R. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade. Cancer Res. 64, 6137–6143 (2004).
  Article CAS Google Scholar
• Perk, J. et al. Reassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibody. Cancer Res. 66, 10870–10877 (2006).
  Article CAS Google Scholar
• Sakurai, D. et al. Crucial role of inhibitor of DNA binding/differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells. J. Immunol. 173, 5801–5809 (2004).
  Article CAS Google Scholar
• Belletti, B. et al. Regulation of Id1 protein expression in mouse embryo fibroblasts by the type 1 insulin-like growth factor receptor. Exp. Cell Res. 277, 107–118 (2002).
  Article CAS Google Scholar
• Borlak, J., Meier, T., Halter, R., Spanel, R. & Spanel-Borowski, K. Epidermal growth factor-induced hepatocellular carcinoma: gene expression profiles in precursor lesions, early stage and solitary tumours. Oncogene 24, 1809–1819 (2005).
  Article CAS Google Scholar
• Viloria-Petit, A. et al. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis. Cancer Res. 61, 5090–5101 (2001).
  CAS PubMed Google Scholar
• Casanovas, O., Hicklin, D.J., Bergers, G. & Hanahan, D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8, 299–309 (2005).
  Article CAS Google Scholar
• Porkka, K., Laakkonen, P., Hoffman, J.A., Bernasconi, M. & Ruoslahti, E. A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo. Proc. Natl. Acad. Sci. USA 99, 7444–7449 (2002).
  Article CAS Google Scholar
• Lyden, D. et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194–1201 (2001).
  Article CAS Google Scholar
• Ohtani, N. et al. Opposing effects of Ets and Id proteins on p16(INK4a) expression during cellular senescence. Nature 409, 1067–1070 (2001).
  Article CAS Google Scholar
• Fong, S. et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc. Natl. Acad. Sci. USA 100, 13543–13548 (2003).
  Article CAS Google Scholar
• Christian, S. et al. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels. J. Cell Biol. 163, 871–878 (2003).
  Article CAS Google Scholar
• Shi, H. et al. Nucleolin is a receptor that mediates antiangiogenic and anti-tumor activity of endostatin. Blood 110, 2899–2906 (2007).
  Article CAS Google Scholar
• Zhao, Q. et al. Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice. Antisense Nucleic Acid Drug Dev. 8, 451–458 (1998).
  Article CAS Google Scholar
• Solit, D.B. et al. 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts. Clin. Cancer Res. 8, 986–993 (2002).
  CAS PubMed Google Scholar
• Holmgren, L., O'Reilly, M.S. & Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1, 149–153 (1995).
  Article CAS Google Scholar
• Doubrovin, M., Serganova, I., Mayer-Kuckuk, P., Ponomarev, V. & Blasberg, R.G. Multimodality in vivo molecular-genetic imaging. Bioconjug. Chem. 15, 1376–1388 (2004).
  Article CAS Google Scholar
• Ponomarev, V. et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 740–751 (2004).
  Article CAS Google Scholar
• Perk, J., Iavarone, A. & Benezra, R. Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5, 603–614 (2005).
  Article CAS Google Scholar
• Ruzinova, M.B. & Benezra, R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13, 410–418 (2003).
  Article CAS Google Scholar
• Akerman, M.E., Chan, W.C., Laakkonen, P., Bhatia, S.N. & Ruoslahti, E. Nanocrystal targeting in vivo. Proc. Natl. Acad. Sci. USA 99, 12617–12621 (2002).
  Article CAS Google Scholar
• Reddy, G.R. et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer Res. 12, 6677–6686 (2006).
  Article CAS Google Scholar
• Corey, D.R. 48000-fold Acceleration of hybridization by chemically modified oligonucleotides. J. Am. Chem. Soc. 117, 9373–9374 (1995).
  Article CAS Google Scholar
• Winkler, F. et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6, 553–563 (2004).
  CAS PubMed Google Scholar
• Shaked, Y. et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313, 1785–1787 (2006).
  Article CAS Google Scholar
• Mabjeesh, N.J. et al. Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells. Cancer Res. 62, 2478–2482 (2002).
  CAS PubMed Google Scholar
• Petit, A.M. et al. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am. J. Pathol. 151, 1523–1530 (1997).
  CAS PubMed PubMed Central Google Scholar
• Henry, S.P., Grillone, L.R., Orr, J.L., Bruner, R.H. & Kornbrust, D.J. Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley rats. Toxicology 116, 77–88 (1997).
  Article CAS Google Scholar
• Trepel, M., Arap, W. & Pasqualini, R. Modulation of the immune response by systemic targeting of antigens to lymph nodes. Cancer Res. 61, 8110–8112 (2001).
  CAS PubMed Google Scholar
• Arap, M.A. et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 6, 275–284 (2004).
  Article CAS Google Scholar
• Kolonin, M.G., Saha, P.K., Chan, L., Pasqualini, R. & Arap, W. Reversal of obesity by targeted ablation of adipose tissue. Nat. Med. 10, 625–632 (2004).
  Article CAS Google Scholar
• Ardelt, P.U. et al. Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands. J. Urol. 169, 1535–1540 (2003).
  Article CAS Google Scholar
• Lee, L. et al. Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum. 46, 2109–2120 (2002).
  Article CAS Google Scholar
• Nowakowski, G.S. et al. A specific heptapeptide from a phage display peptide library homes to bone marrow and binds to primitive hematopoietic stem cells. Stem Cells 22, 1030–1038 (2004).
  Article CAS Google Scholar
• Harrison, J.G. & Balasubramanian, S. Synthesis and hybridization analysis of a small library of peptide-oligonucleotide conjugates. Nucleic Acids Res. 26, 3136–3145 (1998).
  Article CAS Google Scholar